Fonte: Journal of Integrative Medicine. Unidade: FMRP
Assuntos: HOMEOPATIA, COVID-19, ATENÇÃO PRIMÁRIA À SAÚDE, MÉTODO DUPLO-CEGO, INFLUENZA
ABNT
ADLER, Ubiratan Cardinalli et al. Homeopathy for COVID-19 in primary care: a randomized, double-blind, placebo-controlled trial (COVID-Simile study). Journal of Integrative Medicine, v. 20, n. 3, p. 221-229, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.joim.2022.03.003. Acesso em: 18 ago. 2024.APA
Adler, U. C., Adler, M. S., Padula, A. E. M., Hotta, L. M., Cesar, A. de T., Diniz, J. N. M., et al. (2022). Homeopathy for COVID-19 in primary care: a randomized, double-blind, placebo-controlled trial (COVID-Simile study). Journal of Integrative Medicine, 20( 3), 221-229. doi:10.1016/j.joim.2022.03.003NLM
Adler UC, Adler MS, Padula AEM, Hotta LM, Cesar A de T, Diniz JNM, Santos H de F, Martinez EZ. Homeopathy for COVID-19 in primary care: a randomized, double-blind, placebo-controlled trial (COVID-Simile study) [Internet]. Journal of Integrative Medicine. 2022 ; 20( 3): 221-229.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1016/j.joim.2022.03.003Vancouver
Adler UC, Adler MS, Padula AEM, Hotta LM, Cesar A de T, Diniz JNM, Santos H de F, Martinez EZ. Homeopathy for COVID-19 in primary care: a randomized, double-blind, placebo-controlled trial (COVID-Simile study) [Internet]. Journal of Integrative Medicine. 2022 ; 20( 3): 221-229.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1016/j.joim.2022.03.003